uniQure N.V. Earnings
NASDAQ: QUREHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Mon, Nov 9, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.84
uniQure N.V. earnings summary
uniQure N.V. is scheduled to report Sep/2026 earnings on Nov 9, 2026, with analysts expecting EPS of $-0.84. In its most recent report on May 5, 2026 (Q1 2026), QURE posted EPS of $-0.85. Revenue for the quarter was $3.6 million.
Across the last 16 reports, QURE shares moved an average of 7.7% (in either direction) in the first trading session after results, rising 5 times and falling 11 times.
Summary generated from market data by MetaCap's automated system. Methodology
QURE earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| May 5, 2026 | — | $-0.85 | — | -2.2% |
| Mar 2, 2026 | — | $-0.57 | — | +8.8% |
| Nov 10, 2025 | — | $-1.38 | — | -6.9% |
| Jul 29, 2025 | — | $-0.69 | — | -3.0% |
| May 9, 2025 | — | $-0.82 | — | +7.1% |
| Feb 27, 2025 | — | $-1.49 | — | -7.0% |
| Nov 5, 2024 | — | $-0.91 | — | -20.3% |
| Aug 1, 2024 | — | $-1.16 | — | -2.2% |
| May 7, 2024 | — | $-1.36 | — | +1.8% |
| Feb 28, 2024 | — | $-1.52 | — | -6.6% |
| Nov 7, 2023 | — | $-1.88 | — | +13.7% |
| Aug 1, 2023 | — | $-1.44 | — | -9.3% |
| May 9, 2023 | — | $-1.63 | — | -2.8% |
| Feb 27, 2023 | — | $0.15 | — | -9.5% |
| Nov 2, 2022 | — | $-1.02 | — | +14.9% |
| Aug 8, 2022 | — | $-0.84 | — | -6.5% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.